Sonoco (SON) Unit Acquires AAR Cold Chain Solutions Assets
- Banks, telecoms lead Wall Street up; another Dow record
- Western Digital (WDC) Raises Q2 Outlook
- bluebird bio (BLUE) to Offer $200M of Common Stock
- Dave & Buster's Entertainment (PLAY) Tops Q3 EPS by 11c, Raises FY Revenue Guidance
- After-Hours Stock Movers 12/06: (PLAY) (ANTH) (WDC) Higher; (AVAV) (ESV) (BLUE) Lower (more...)
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Sonoco ThermoSafe, a unit of Sonoco (NYSE: SON) and a leading global provider of temperature-assurance packaging, has acquired the PharmaPort 360™ assets, licenses, trademarks and manufacturing rights from AAR, to enter the active temperature-controlled cargo containers market.
Sonoco ThermoSafe will own and lease the PharmaPort 360 containers globally while signing a multi-year agreement with AAR to manufacture, repair and perform maintenance services. The PharmaPort 360 is an innovative active container that uses regenerative heat exchangers to maintain stringent temperature control for high-value cargo. These containers, which are approved by the U.S. Federal Aviation Authority (FAA), can be used to safely ship temperature-sensitive pharmaceuticals, blood plasma and other biological cargo via air or ground transportation.
Vicki Arthur, vice president of Sonoco Protective Solutions, said, “This acquisition is in line with our strategy to provide the best temperature-controlled shipping solution irrespective of technology platform (passive or active) to meet our customers’ critical needs for shipping high-value pharmaceuticals and biologics globally. Sonoco is committed to investing in passive and active technologies, like that of PharmaPort 360, and expanding its presence globally in the temperature-controlled packaging industry.”
“This transaction leverages AAR’s specialty container manufacturing capabilities and its focus on aftermarket support, while partnering with an industry leader in the sales and fulfillment requirements associated with transportation of products for the pharmaceutical industry,” said AAR Senior Vice President of Technology Products Lee Krantz.
PharmaPort® containers provide safe, reliable 5°C door-to-door transport of pharmaceuticals and other high-value cargo. Its exclusive Pro-Tectic® regenerative phase change technology uses active cooling and heating to maintain assured product temperature stability through an ambient temperature range of -40°C to +60°C. From initial loading in a source facility to unpacking at the destination, PharmaPort® containers transition easily through standard international air and ground transport systems. This allows common carriers and third-party logistics providers to offer precision temperature-controlled service using a proven, self-contained modular unit. To learn more, please visit www.thermosafe.com/active
“PharmaPort 360 is a strategic addition to our product offerings, making Sonoco ThermoSafe a valued partner for many global pharmaceutical and freight forwarding companies by providing the widest range of passive and active bulk temperature-controlled packaging solutions,” said Russell Grissett, vice president of Sonoco ThermoSafe. “Additionally, Sonoco’s global footprint and deep understanding of the temperature-assurance packaging market will help expand the availability of PharmaPort 360 active containers across global regions.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft (MSFT) and LinkedIn's (LNKD) Proposed Merger Cleared in Europe, with Conditions
- Alaska Air Group (ALK) Cleared by DOJ to Acquire Virgin America (VA)
- Kroger (KR) Chief Digital Officer Dougherty to Retire; Successor Named